The name change is administrative and does not alter the company's fundamentals. Monitor the next 10-Q or 20-F for any improvement in the going-concern status or remediation of internal control weaknesses.
Price Chart
Executive Summary
TFA Therapeutics, Inc. (f/k/a Cordyceps Sunshine Biotech Holdings Co., Ltd.) filed a 6-K reporting a corporate name change from 'Cordyceps Sunshine Biotech Holdings Co., Ltd.' to 'TFA Therapeutics, Inc.,' effective July 20, 2026. The ticker symbol remains unchanged. This is a purely administrative event with no operational or financial impact, though it may signal a strategic rebranding effort against the backdrop of a going-concern qualification and material weaknesses in internal controls disclosed in the prior 20-F annual report.
Key Facts
- Shareholders passed a special resolution on July 12, 2026 to change the company name to TFA Therapeutics, Inc.
- The name change was filed with the Cayman Islands Registry on July 20, 2026, and the certificate was received on July 22, 2026.
- The company's ticker symbol (RAJAF) remains unchanged.
- The prior 20-F annual report (filed May 15, 2026) disclosed a net loss of $154,822, a going-concern qualification, and material weaknesses in internal controls.
Financial Impact
No financial impact from this filing.
Risk Factors
- The company has a going-concern qualification and negative working capital of $4.19M as of the last annual report.
- Material weaknesses in internal controls over financial reporting remain unremediated.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-081806 |
| Document: ea029932001ex3-1.htm | 0001213900-26-081806 |
| Document: 0001213900-26-081806-index-headers.html | 0001213900-26-081806 |
| Document: 0001213900-26-081806-index.html | 0001213900-26-081806 |
| Document: 0001213900-26-081806.txt | 0001213900-26-081806 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 7w ago | 6-K | $9.18 $9.18 | · 0.00% | ▼ −0.08% | $9.18 (−0.00%) |
Jul 27, 2026 13w ago | 6-K | $9.18 $9.18 | · 0.00% | ▼ −3.38% | $9.18 (+0.00%) |
Jun 25, 2026 17w ago | 6-K | $9.18 $9.18 | · 0.00% | ▼ −0.53% | $9.18 (+0.00%) |
May 15, 2026 23w ago | 20-F | $9.18 $9.18 | · 0.00% | ▲ +1.58% | $9.18 (−0.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers